Molecular testing in endometrial carcinoma (Joint recommendation of Czech Oncological Society, Oncogynecological Section of the Czech Gynecological and Obstetrical Society, Society of Radiation Oncology, Biology and Physics, and the Society of Czech Pathologists).
Pavel Dundr, David Cibula, Martin Doležel, Pavel Fabian, Jindřich Fínek, Tomáš Jirásek, Radoslav Matěj, Luboš, Petruželka, Lukáš Rob, Aleš Ryška, Marián Švajdler, Vít Weinberger, Michal Zikán
{"title":"Molecular testing in endometrial carcinoma (Joint recommendation of Czech Oncological Society, Oncogynecological Section of the Czech Gynecological and Obstetrical Society, Society of Radiation Oncology, Biology and Physics, and the Society of Czech Pathologists).","authors":"Pavel Dundr, David Cibula, Martin Doležel, Pavel Fabian, Jindřich Fínek, Tomáš Jirásek, Radoslav Matěj, Luboš, Petruželka, Lukáš Rob, Aleš Ryška, Marián Švajdler, Vít Weinberger, Michal Zikán","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Molecular classification of endometrial carcinoma is becoming an important part of the diagnostic process with direct therapeutic implications. Recent international guidelines, including the joint ESGO-ESTRO-ESP recommendation, include the molecular classification into standard diagnostic algorithms. Molecular testing of endometrial carcinomas is also recommended in the latest (5th) edition of the WHO classification of Female Genital Tumors. Due to the need to implement these recommendations in practice, representatives of four professional societies of Czech Medical Association of J. E. Purkyně (Czech Oncological Society, Oncogynecological Section of the Czech Gynecological and Obstetrical Society, Society of Radiation Oncology, Biology and Physics, and the Society of Czech Pathologists) organized a meeting focused on this topic. The result of this meeting is a joint recommendation for molecular testing of endometrial carcinoma in routine diagnostic practice in the Czech Republic.</p>","PeriodicalId":9861,"journal":{"name":"Ceskoslovenska patologie","volume":"57 3","pages":"181-187"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ceskoslovenska patologie","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Molecular classification of endometrial carcinoma is becoming an important part of the diagnostic process with direct therapeutic implications. Recent international guidelines, including the joint ESGO-ESTRO-ESP recommendation, include the molecular classification into standard diagnostic algorithms. Molecular testing of endometrial carcinomas is also recommended in the latest (5th) edition of the WHO classification of Female Genital Tumors. Due to the need to implement these recommendations in practice, representatives of four professional societies of Czech Medical Association of J. E. Purkyně (Czech Oncological Society, Oncogynecological Section of the Czech Gynecological and Obstetrical Society, Society of Radiation Oncology, Biology and Physics, and the Society of Czech Pathologists) organized a meeting focused on this topic. The result of this meeting is a joint recommendation for molecular testing of endometrial carcinoma in routine diagnostic practice in the Czech Republic.
子宫内膜癌的分子分型已成为诊断过程的重要组成部分，具有直接的治疗意义。最近的国际指南，包括ESGO-ESTRO-ESP联合推荐，将分子分类纳入标准诊断算法。最新(第5版)世卫组织女性生殖器肿瘤分类也推荐对子宫内膜癌进行分子检测。由于需要在实践中执行这些建议，捷克医学协会四个专业协会的代表J. E. Purkyně(捷克肿瘤学会、捷克妇产科学会妇科肿瘤科、放射肿瘤学、生物学和物理学学会以及捷克病理学家学会)组织了一次关于这一主题的会议。本次会议的结果是联合推荐子宫内膜癌分子检测在捷克共和国的常规诊断实践。
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
